IMA-401

N/A

Report date: 2026/03/26 20:00:17

Base Information

Drug NameIMA-401
Drug Alias NameIMA-401MAGE A4/8 TCERIMA401 TCER
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > T cell engagers
Mechanisms of ActionMelanoma-associated antigen 4 modulatorsMelanoma-associated antigen 8 modulators
TargetsMelanoma-associated antigen 4Melanoma-associated antigen 8
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesImmatics Biotechnologies Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesImmatics Biotechnologies GmbhBristol-Myers Squibb Company
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A